Sinnhaftigkeit des PSA-ScreeningsMeaningfulness of PSA screening

被引:0
作者
Christian Arsov
Peter Albers
机构
[1] Heinrich-Heine Universität Düsseldorf,Universitätsklinikum Düsseldorf, Medizinische Fakultät
来源
Der Onkologe | 2017年 / 23卷 / 6期
关键词
Prostataspezifisches Antigen; Prostatakarzinom; Screening; Überdiagnose; Risikoadaptiertes Screening; Prostate-specific antigen; Prostate carcinoma; Screening; Overdiagnosis; Risk-adapted screening;
D O I
10.1007/s00761-017-0205-y
中图分类号
学科分类号
摘要
引用
收藏
页码:429 / 437
页数:8
相关论文
共 369 条
[1]  
Ferlay J(2013)Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 1374-1403
[2]  
Steliarova-Foucher E(2004)Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study J Urol 172 90-93
[3]  
Lortet-Tieulent J(2014)Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up Lancet 384 2027-2035
[4]  
Rosso S(2012)Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up J Natl Cancer Inst 104 125-132
[5]  
Coebergh JW(2004)Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial Prostate 59 311-318
[6]  
Comber H(2009)15-year followup of a population based prostate cancer screening study J Urol 181 1615-1621
[7]  
Forman D(2011)Randomised prostate cancer screening trial: 20 year follow-up BMJ 342 d1539-891
[8]  
Bray F(2010)Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials BMJ 341 c4543-956
[9]  
Antenor JA(2011)Screening for prostate cancer: an updated Cochrane systematic review BJU Int 107 882-605
[10]  
Han M(2013)Screening for prostate cancer Cochrane Database Syst Rev 1 CD004720-1340